Issue link: https://viewer.e-digitaledition.com/i/1045913
MERGING THE CAPABILITIES OF MRI AND ULTRASOUND TECHNOLOGY IN REAL TIME, PENN STATE HEALTH MILTON S. HERSHE Y MEDICAL CENTER USES MRI-GUIDED FUSION BIOP SY TO MORE ACCUR ATELY DE TECT THE PRESENCE AND AGGRESSIVENESS OF PROSTATE CANCER. THIS INNOVATIVE TECHNIQUE FACILITATES ACCUR ATE PROSTATE CANCER DIAGNOSIS WHILE REDUCING THE POSSIBILIT Y OF NONDIAGNOSTIC BIOP SIES AND THE NEED FOR REPE AT PROCEDURES. " Our rate of positive biopsy results has increased significantly when using this technology. More importantly, we're finding a higher percentage of clinically significant cancers that require treatment." — JAY D. RAMAN, MD, FACS, CHIEF OF THE DIVISION OF UROLOGY AT PENN STATE HEALTH SURGICAL SPECIALTIES ULTRASOUND-GUIDED BIOPSY HAS long been used to diagnose prostate cancer. It a llows visua lization of the prostate and ser ves as a tool for urologists to biopsy specif ic anatomic zones. A limitation of ultrasound biopsy, however, is accurate identification of high-risk regions and therefore the potential for sampling error. Magnetic resonance imaging (MRI), which has superior delineation of the prostate, serves as an imaging tool to better localize concerning lesions and more precisely biopsy these areas by ultrasound guidance. "In the past, we relied on a cognitive MRI biopsy," says Jay D. Raman, MD, FACS, chief of the Division of Urology at Penn State Health Surgical Specialties. " We reviewed the MRI before a biopsy, made a mental note of where these high-risk areas were and sampled those areas under ultrasound." A lthough this was a step to improve diagnosis, cognitive biopsies were still limited by sampling error, especially if the tissue was taken from outside the prescribed area highlighted on MRI. To help resolve this issue and improve the procedure's accuracy, the Milton S. Hershey Medical Center began performing MRI- guided fusion biopsy in December 2017. This recently developed technique unites existing technologies in a unique way to enhance diagnostic precision, according to Dr. Raman, who performs approximately 15 such procedures each month. "MRI-guided fusion biopsy fuses the pre-existing MRI images with the ultrasound in real-time using computer software," he says. " We can now take more precisely targeted biopsies of high-risk areas thanks to the superimposed MRI images." WIDE-RANGING BENEFITS Unlike some other cancers, prostate cancer is a heterogenous entity that encompasses low-grade (nonaggressive) to high-grade (aggressive) cancers. Therefore, even for a patient with prostate cancer, treatment can be tailored or individualized based on their type of disease. Consequently, it is critical to have accurate biopsy techniques to avoid potentially under- or over-treating patients. Specifically, a tissue sample that doesn't accurately reflect a patient's condition can lead to unnecessary treatment or delay lifesaving treatment by years. "Some prostate cancers in certain patients can be safely managed by active surveillance," Dr. Raman says. "On the other hand, patients with more clinically significant cancers should undergo therapy based on national guidelines." MRI-guided fusion biopsy can also play a role in patients with prior negative biopsies or those with prostate cancer on surveillance regimens. "The superior t a rget i n g w it h M R I t ech nolog y i s invaluable. It's not uncommon for MRI- guided fusion biopsies to detect significant cancer in patients who had negative biopsies in the past or to identify more significant areas of cancer in patients on active surveillance," Dr. Raman says. COLLABORATIVE, LOCAL CARE At present, in central Pennsylvania, Hershey Medical Center is one of the few sites where MRI-guided fusion biopsy is performed, according to Dr. Raman. However, he adds, the Medical Center partners with referring physicians to complete the local circle of care. "We offer this resource so that local patients don't have to travel several hours for fusion-guided biopsy," Dr. Raman says. "That's why we work with local physicians on treatment options. It's a collaboration to improve patient care rather than a competition for business." Hershey Medical Center Achieves More Accurate Prostate Cancer Diagnosis with MRI-Guided Biopsy BY JOSH GARCIA The top image is the actual MRI. The yellow outline on the bottom image represents a suspicious area targeted with MRI-guided fusion biopsy. To refer a patient or learn more about MR I-guided fusion biopsy, visit cancer. psu.edu/prostate-cancer and click on the Symptoms a n d D i a g n o s i s t a b o r call 717-531-8887. ■ 0 4 0 4❱❱❱❱❱ P R E C I S I O N D I A G N O S I S

